DE LUCA, GIUSEPPE
 Distribuzione geografica
Continente #
EU - Europa 6.975
NA - Nord America 6.496
AS - Asia 1.212
Continente sconosciuto - Info sul continente non disponibili 12
AF - Africa 3
SA - Sud America 3
OC - Oceania 1
Totale 14.702
Nazione #
US - Stati Uniti d'America 6.455
IE - Irlanda 2.793
DE - Germania 1.311
UA - Ucraina 1.054
SE - Svezia 1.009
CN - Cina 742
FI - Finlandia 518
HK - Hong Kong 225
IN - India 169
IT - Italia 140
FR - Francia 50
IR - Iran 48
GB - Regno Unito 40
CA - Canada 38
VN - Vietnam 16
BE - Belgio 15
NL - Olanda 15
EU - Europa 12
RO - Romania 10
TR - Turchia 6
PL - Polonia 5
RU - Federazione Russa 5
ES - Italia 4
MX - Messico 3
AT - Austria 2
BR - Brasile 2
ID - Indonesia 2
IL - Israele 2
NG - Nigeria 2
RS - Serbia 2
BG - Bulgaria 1
CL - Cile 1
EG - Egitto 1
JP - Giappone 1
MY - Malesia 1
NZ - Nuova Zelanda 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 14.702
Città #
Dublin 2.793
Jacksonville 1.912
Dearborn 1.051
Wilmington 700
Lawrence 382
Princeton 382
Beijing 286
San Mateo 261
Chandler 254
Hong Kong 224
Ashburn 172
Ann Arbor 168
Bremen 165
Andover 163
Hefei 71
Düsseldorf 66
Nanjing 63
Norwalk 54
Houston 53
Woodbridge 51
Kunming 50
Piemonte 40
Leawood 36
Fairfield 35
Monmouth Junction 33
Jinan 32
Guangzhou 26
Ardabil 22
Toronto 21
Torino 20
Seattle 19
Nanchang 18
Helsinki 17
Dong Ket 16
Hebei 16
Brussels 15
Shenyang 14
Boardman 13
Xian 13
Zanjan 12
Fuzhou 11
Horia 10
Augusta 9
Quzhou 9
Wuhan 9
Casalecchio Di Reno 8
Chengdu 8
San Diego 8
Wenzhou 8
Zhengzhou 8
Baotou 7
Changsha 7
Hangzhou 7
Simi Valley 7
Winnipeg 7
Sacramento 6
Cagliari 5
Cambridge 5
Chongqing 5
Des Moines 5
Jiaxing 5
Kocaeli 5
Ottawa 5
Redwood City 5
Shaoxing 5
Canelli 4
Harbin 4
Henderson 4
Livorno Ferraris 4
London 4
Nanning 4
Ningbo 4
Polska 4
Strasbourg 4
Tianjin 4
Charlotte 3
Grafenhausen 3
Mexico City 3
Milan 3
Philadelphia 3
Rome 3
Shanghai 3
Turin 3
Verbania 3
Bangalore 2
Changchun 2
Delhi 2
Grafing 2
Gunzenhausen 2
Jinhua 2
League City 2
Los Angeles 2
Montréal 2
Mülheim 2
New Delhi 2
Padova 2
Salsomaggiore 2
Valencia 2
Viladecans 2
Alvin 1
Totale 10.011
Nome #
Paclitaxel-eluting versus bare metal stents in primary PCI: a pooled patient-level meta-analysis of randomized trials. 82
PCI techniques 82
Impact of hypertension on clinical outcome in STEMI patients undergoing primary angioplasty with BMS or DES: insights from the DESERT cooperation. 81
Switching from clopidogrel to prasugrel in patients having coronary stent implantation. 79
Direct coronary stenting: Effects on coronary blood flow, immediate and late clinical outcome 73
Mechanical prevention of distal embolization: Rationale and trial results 72
ACC/AHA and ESC guidelines 71
Mechanical reperfusion for STEMI: from randomized trials to clinical practice 70
Mean platelet volume is not associated with platelet reactivity and the extent of coronary artery disease in diabetic patients 70
Impact of gender difference on vitamin D status and its relationship with the extent of coronary artery disease 67
Body Mass Index and Platelet Reactivity During Dual Antiplatelet Therapy With Clopidogrel or Ticagrelor 67
Pharmacological facilitation in primary angioplasty: myth or reality? 65
Redefining the success of mechanical reperfusion: ST-segment resolution 65
Coronary intravascular ultrasound (IVUS): Contemporary applications and bases for the future 65
Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease. 65
P2Y12 inhibitors: pharmacologic mechanism and clinical relevance 64
Benefits from intracoronary as compared to intravenous abciximab administration for STEMI patients undergoing primary angioplasty: a meta-analysis of 8 randomized trials. 63
Balloon angioplasty or BMS? 63
Impact of multivessel disease on myocardial perfusion and survival among patients undergoing primary percutaneous coronary intervention with glycoprotein IIb/IIIa inhibitors. 63
Analysis of beta1 and beta2-adrenergic receptors polymorphism in patients with apical ballooning cardiomyopathy 63
Acetylsalicylic acid desensitization in patients with coronary artery disease: A comprehensive overview of currently available protocols 63
Association between high-residual platelet reactivity in patients receiving dual antiplatelet therapy, Vitamin D plasma levels and Vitamin D Binding Protein rs7041 polymorphism. 62
Association between high-residual platelet reactivity in patients receiving dual antiplatelet therapy, Vitamin D plasma levels and Vitamin D Binding Protein rs7041 polymorphism. 62
Relationship Between Glycoprotein IIIa Platelet Receptor Gene Polymorphism and Coronary Artery Disease 62
ANMCO/SICI-GISE paper on antiplatelet therapy in acute coronary syndrome 61
Prediction of long-term effetcs of revascularization on regional and global left ventricular function by dobutamine echocardiography and rest Tl-201 imaging alone and in combination in patients with chronic coronary artery disease 61
Platelet HPA-1 a/HPA-1 b polymorphism and the risk of periprocedural myocardial infarction in patients undergoing elective PCI. 60
Platelet Larger Cell Ratio and High-on Treatment Platelet Reactivity During Dual Antiplatelet Therapy 60
Immature platelet fraction and the extent of coronary artery disease: a single centre study. 59
LOW-DOSE DOBUTAMINE ECHOCARDIOGRAPHY PREDICTING FUNCTIONAL RECOVERY AFTER CORONARY REVASCULARIZATION 58
Platelet reactivity in patients with impaired renal function receiving dual antiplatelet therapy with clopidogrel or ticagrelor 58
Impact of long-term dual antiplatelet therapy on immature platelet count and platelet reactivity. 58
Randomized evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: Rationale and design of the REDUCE trial 58
Impact of duration of clopidogrel prescription on outcome of DES as compared to BMS in primary angioplasty: a meta-regression analysis of randomized trials 57
Cytokines release inhibition from activated monocytes, and reduction of in-stent neointimal growth in humans 57
Bivalirudin as compared to unfractionated heparin among patients undergoing coronary angioplasty A meta-analyis of randomised trials 57
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor 57
Impact of age on mean platelet volume and its relationship with coronary artery disease: A single-centre cohort study 57
Impact of Diabetes on Homocysteine Levels and Its Relationship with Coronary Artery Disease: A Single-Centre Cohort Study 57
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor: Reply 57
Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. 57
Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient- level meta-analysis of randomized trials 56
Optical coherence tomography for guidance of treatment of in-stent restenosis with cutting balloons. 56
Combination between mean platelet volume and platelet distribution width to predict the prevalence and extent of coronary artery disease: results from a large cohort study 56
Impact of advanced age on myocardial perfusion, distal embolization, and mortality patients with ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb-IIIa inhibitors. 56
Glycosylated hemoglobin and the risk of periprocedural myocardial infarction in non-diabetic patients 55
Time-to-treatment and infarct size in STEMI patients undergoing primary angioplasty 54
Clinical efficacy and safety of intracoronary vs. intravenous abciximab administration in STEMI patients undergoing primary percutaneous coronary intervention: A meta-analysis of randomized trials. 54
A meta-analytic overview of thrombectomy during primary angioplasty 54
Left ventricular angiography and other angiocardiographic techniques 54
PCI for chronic stable coronary artery disease 54
Old and New Drugs for Treatment of Stable Angina: New Anti-Anginal Drugs and Coronary Revascularization. 54
Impact of diabetes on neutrophil-to-lymphocyte ratio and its relationship to coronary artery disease 54
Platelet PIA1/PIA2 polymorphism and the risk of periprocedural myocardial infarction in patients with acute coronary syndromes undergoing coronary angioplasty. 54
Bivalirudin as compared to unfractionated heparin in patients undergoing percutaneous coronary revascularization: A meta-analysis of 22 randomized trials 54
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor. 54
Association between high-residual platelet reactivity in patients receiving dual antiplatelet therapy, Vitamin D plasma levels and Vitamin D Binding Protein rs7041 polymorphism. 54
Immature platelet fraction and the extent of coronary artery disease: a single centre study. 54
High-Density Lipoproteins and Coronary Artery Disease: A Single-Center Cohort Study 53
Aging, impaired myocardial perfusion and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty 52
PCI for acute myocardial infarction 52
An unusual case of ECG ST-segment elevation 52
Comprehensive meta-analysis of radial vs femoral approach in primary angioplasty for STEMI. 52
Absolute eosinophils count and the extent of coronary artery disease: a single centre cohort study. 52
Impact of atorvastatin or rosuvastatin co-administration on platelet reactivity in patients treated with dual antiplatelet therapy 52
Haemoglobin levels do not correlate with the extent of coronary artery disease: results from a large cohort study. 52
Impact of adenosine A2a receptor polymorphism rs5751876 on platelet reactivity in ticagrelor treated patients 52
Adjuncitve pharmacotherapy: Anticoagulation 51
Neutrophil to Lymphocyte Ratio and the Extent of Coronary Artery Disease: Results from a Large Cohort Study 51
Long-term outcome of drug-eluting stents compared with bare metal stents in st-segment elevation myocardial infarction results of the paclitaxel- or sirolimus-eluting stent versus bare metal stent in primary angioplasty (paseo) randomized trial (Retraction in: Circulation (2010) 121:8 (e228)) 51
Cuore: Cenni di anatomia, fisiologia, esame clinico, diagnostica strumentale invasiva e non, cardiologia interventistica 50
Reduced antiplatelet therapy after drug-eluting stenting: Multicenter Janus Flex Carbostent implantation with short dual antiplatelet treatment - two or sIX months. MATRIX Study. 50
Apical-sparing Tako-tsubo: A case report 50
Absence of seasonal variation in myocardial perfusion, enzymatic infarct size, and mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty 50
Uric acid does not affect the prevalence and extent of coronary artery disease. Results from a prospective study 50
Diabetes mellitus, glucose control parameters and platelet reactivity in ticagrelor treated patients 50
Prevalence and predictors of high-on treatment platelet reactivity with ticagrelor in ACS patients undergoing stent implantation. 50
Prevalence and predictors of high-on treatment platelet reactivity with ticagrelor in ACS patients undergoing stent implantation 50
Benefits from new ADP-antagonists as compared to clopidogrel in patients with stable angina or acute coronary syndrome undergoing invasive management: a meta-analysis of randomized trials. 50
Impact of Preprocedural TIMI Flow on Myocardial Perfusion, Distal Embolization and Mortality in Patients with ST-Segment Elevation Myocardial Infarction Treated by Primary Angioplasty and Glycoprotein IIb/IIIa Inhibitors 50
Stenting and abciximab in primary angioplasty: a review of current status 49
Mean platelet volume and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor 49
Impact of time from symptom onset to drug administration on outcome in patients undergoing glycoprotein IIb-IIIa facilitated primary angioplasty (from the EGYPT Cooperation) 49
Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease. 49
Optical coherence tomography guidance during bioresorbable vascular scaffold implantation 49
Antithrombotic Therapy After Percutaneous Aortic Valve Implantation: Large Gaps for a Matter of Extreme Importance. Response 49
Assesment of TIMI flow and blush 48
Advances in antithrombotic therapy as adjunct to reperfusion therapies for ST-segment elevation myocardial infarction 48
PlA(1)/PlA(2) polymorphism does not influence response to Gp IIb-IIIa inhibitors in patients undergoing coronary angioplasty. 48
Effects of HDL-modifiers on cardiovascular outcomes: A meta-analysis of randomized trials. 48
Homocysteine levels influence platelet reactivity in coronary artery disease patients treated with acetylsalicylic acid. 48
Impact of sex on uric acid levels and its relationship with the extent of coronary artery disease: A single-centre study 48
Impact of anticoagulation strategy with bivalirudin or heparin on nonaccess site bleeding in percutaneous coronary interventions: A meta-analysis of randomized trials 48
Adjunctive benefits from low-molecular-weight heparins as compared to unfractionated heparin among patients with ST-segment elevation myocardial infarction treated with thrombolysis. A meta-analysis of the randomized trials 48
Technical Aspects: OCT, IVUS and Angioscopy 47
Adjunctive antithrombotic therapy during Primary PCI 47
Mean platelet volume and the risk of periprocedural myocardial infarction in patients undergoing coronary angioplasty 47
The Inconclusive Results of the Studies on Glycoprotein IIIa Platelet Receptor Gene Polymorphism and Coronary Artery Disease: An Area of Darkness. 47
Homocysteine and risk of periprocedural myocardial infarction in patients undergoing coronary stenting. 47
Impact of red blood cells count and high density lipoproteins with the prevalence and extent of coronary artery disease 47
Totale 5.637
Categoria #
all - tutte 78.586
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.586


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201921 0 0 0 0 0 0 0 0 0 0 6 15
2019/20203.726 5 3 320 18 639 653 894 180 387 263 363 1
2020/20212.188 343 2 334 11 252 50 344 6 388 35 395 28
2021/20222.083 72 54 302 135 200 8 163 35 155 60 385 514
2022/20234.395 412 147 211 54 246 262 81 193 2.640 8 87 54
2023/2024773 65 71 78 18 279 2 225 20 3 9 3 0
Totale 15.455